Neuroprotective Properties of Wild Medicinal Mushroom, Sanguinoderma rugosum (Agaricomycetes), Extracts against Glutamate-Induced Hippocampal Cells

Neurological diseases are increasingly recognized as a health burden worldwide, mainly affecting the elderly population. Sanguinoderma rugosum (=Amauroderma rugosum) is a wild medicinal mushroom traditionally used to alleviate inflammation and prevent seizures. The present study aimed to investigate the neuroprotective and neurorescue effects as well as the possible mechanisms of S. rugosum extracts on glutamate-induced HT-22 mouse hippocampal neuronal cells. The mycelia of S. rugosum were subjected to submerged liquid fermentation followed by solvent extraction and fractionation. The neurotoxicity, neuroprotective, and neurorescue activities of S. rugosum extracts were assessed via the MTT viability assay at 24 and 48 h. The effects of S. rugosum extracts on glutamate-induced oxidative stress and cell death were investigated through flow cytometry. Gas chromatography/mass spectrometry (GC/MS) analysis was conducted to identify the bioactive compounds in the S. rugosum hexane fraction (SR-HF). All extracts were noncytotoxic toward HT-22 cells. Pretreatment with S. rugosum ethanolic extract (SR-EE; 12.5 μg/mL) or SR-HF (100 μg/mL) markedly (P < 0.05) improved the loss of cell viability and attenuated the accumulation of reactive oxygen species production. Pretreatment with SR-HF was also demonstrated to inhibit glutamate-induced cell death. The MTT assay showed that all extracts generally rescued glutamate-induced HT-22 cells at 24 and 48 h. The GC/MS analysis revealed the existence of 11 bioactive components in SR-HF, with linoleic acid, ergosterol, and ethyl linoleate being the main chemical constituents. The current findings suggest that SR-HF could be used as a potential therapeutic intervention to ameliorate oxidative stress and neuroinflammation.